ANI Pharmaceuticals Inc (ANIP)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data for ANI Pharmaceuticals Inc, the Days of Sales Outstanding (DSO) ratio is not available for the periods mentioned, as the values are indicated as "— days." This lack of specific DSO values prevents a detailed analysis of ANI Pharmaceuticals Inc's efficiency in collecting accounts receivable and managing its working capital through the perspective of sales outstanding.
To provide a more comprehensive analysis of ANI Pharmaceuticals Inc's financial performance and efficiency in managing its accounts receivable, it would be beneficial to obtain actual DSO values for the periods in question. DSO is a key metric used to assess the effectiveness of a company in converting its sales into cash, and a low DSO typically indicates efficient receivables management. It helps in evaluating how quickly a company is collecting payments from its customers and can highlight any potential liquidity or credit risk issues.
Having access to the DSO values would allow for a deeper evaluation of ANI Pharmaceuticals Inc's credit policies, collection procedures, and overall financial health. This metric could also aid in comparing the company's performance with industry peers and identifying trends in its accounts receivable management over time.
Peer comparison
Dec 31, 2024